News
treatment, and monitoring, based on infection stratification may fundamentally improve outcomes of patients with SLE-DAH. Comprehensive management algorithm for SLE-DAH. SLE, systemic lupus ...
Recurrent lupus nephritis pathology in the kidney transplant may not appear the same as previous disease in the native kidney.
A wave of diagnostic tests—some here, some coming—can identify cancer and Alzheimer’s at earlier stages and predict flare-ups ...
Margrit Wiesendanger, MD, PhD, discusses how lupus treatment is evolving from traditional therapies to more targeted options like biologics, with promising advances now being explored in clinical ...
Based on the study findings, the investigators proposed an algorithm for laboratory workup of transplant candidates and recipients with lupus nephritis: “[Recurrent lupus nephritis] was notable ...
By the next morning, Dr. Fajgenbaum had replied, suggesting an unconventional combination of chemotherapy, immunotherapy and steroids previously untested as a treatment for Coates’s disorder.
Selena Gomez previously discussed how her lupus treatment has caused her weight to fluctuate. As social media critics pointed out the actress’ slimmer frame during Sunday’s 2025 SAG Awards ...
Please provide your email address to receive an email when new articles are posted on . Twelve years is a long time by most measures, but in a field has rapidly changing as lupus nephritis ...
THE RESULTS ARE PROMISING. IN 2021, THE FIRST LUPUS PATIENT RECEIVED THE TREATMENT IN GERMANY. DOCTOR CARRICO SAYS IT’S A GAME CHANGER. WITHOUT THIS TREATMENT, WE WOULDN’T KNOW WHAT TO DO.
Zasocitinib is under clinical development by Takeda Pharmaceutical and currently in Phase I for Systemic Lupus Erythematosus ... Zasocitinib is under development for the treatment of moderate to ...
This collaboration offers the potential to improve the lives of lupus patients by providing a more effective treatment solution than what currently exists. This partnership combines LIVEKIDNEY.BIO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results